Skip to main content
. 2011 Nov;30(6):431–451. doi: 10.1016/j.preteyeres.2011.06.003

Fig. 15.

Fig. 15

Different performances of RPE detection in a patient with neovascular AMD. (A) Cirrus OCT (Zeiss Meditec), (B) Spectralis OCT (Heidelberg Engineering), (C) PS-OCT. (D) Retinal thickness map (inner limiting membrane to RPE) retrieved from Cirrus OCT, (E) retinal thickness map retrieved from Spectralis OCT, (F) retinal thickness map obtained with PS-OCT (areas with RPE atrophy are marked in gray). The arrows in (C) and (F) point to locations with RPE atrophy (reprinted from Ahlers et al. (2010)).